TerrAscend (TSNDF) Depreciation & Amortization - Total (2021 - 2026)
TerrAscend (TSNDF) reported Depreciation & Amortization - Total of $2.4 million for Q1 2026, down 1.75% year-over-year from $2.4 million in Q1 2025, and up 2.74% quarter-over-quarter from $2.3 million in Q4 2025.
TerrAscend (TSNDF) Depreciation & Amortization - Total (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Depreciation & Amortization - Total data on file, last reported at $2.4 million in Q1 2026.
- Depreciation & Amortization - Total for Q1 2026 came in at $2.4 million, down 1.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.1 million (changed 0.46% YoY), and the FY2025 annual result was $9.1 million, up 2.09% from the prior year.
- Depreciation & Amortization - Total advanced to $2.4 million in Q1 2026 per TSNDF's latest filing, from $2.3 million in the prior quarter.
- Over five years, Depreciation & Amortization - Total peaked at $3.4 million in Q2 2023 and troughed at -$1.0 million in Q4 2023.
- A 5-year average of $2.3 million and a median of $2.4 million in 2026 frame the typical range for Depreciation & Amortization - Total.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization - Total surged 986.94% in 2022, then slumped 142.93% in 2023.
- A 5-year view of Depreciation & Amortization - Total shows it stood at $2.4 million in 2022, then plunged by 142.93% to -$1.0 million in 2023, then surged by 322.3% to $2.3 million in 2024, then dropped by 0.09% to $2.3 million in 2025, then increased by 2.74% to $2.4 million in 2026.
- Business Quant data shows TSNDF's Depreciation & Amortization - Total at $2.4 million in Q1 2026, $2.3 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | TerrAscend | - | - | 34.60 Mn | 2.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.36 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 3.04 Mn |
| Dec 31, 2023 | -1.04 Mn |
| Sep 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Mar 31, 2023 | 3.26 Mn |
| Dec 31, 2022 | 2.41 Mn |
| Sep 30, 2022 | 2.71 Mn |
| Jun 30, 2022 | 3.03 Mn |
| Mar 31, 2022 | 2.19 Mn |
| Dec 31, 2021 | 222,000.00 |
| Sep 30, 2021 | 2.14 Mn |
| Jun 30, 2021 | 1.81 Mn |